AR035511A1 - Procedimiento para preparar una cefalosporina e intermediarios de sintesis - Google Patents
Procedimiento para preparar una cefalosporina e intermediarios de sintesisInfo
- Publication number
- AR035511A1 AR035511A1 ARP010105609A ARP010105609A AR035511A1 AR 035511 A1 AR035511 A1 AR 035511A1 AR P010105609 A ARP010105609 A AR P010105609A AR P010105609 A ARP010105609 A AR P010105609A AR 035511 A1 AR035511 A1 AR 035511A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- aryl
- formula
- carboxylate
- mono
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- HOKIDJSKDBPKTQ-UHFFFAOYSA-N 3-(acetyloxymethyl)-7-[(5-amino-5-carboxypentanoyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C(NC(=O)CCCC(N)C(O)=O)C12 HOKIDJSKDBPKTQ-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 14
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 8
- 150000001875 compounds Chemical class 0.000 abstract 5
- 150000007942 carboxylates Chemical class 0.000 abstract 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- -1 carboxylate salt Chemical class 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 125000001271 cephalosporin group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000007822 coupling agent Substances 0.000 abstract 1
- 150000004292 cyclic ethers Chemical group 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000006502 nitrobenzyl group Chemical group 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
- C07D501/06—Acylation of 7-aminocephalosporanic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25101400P | 2000-12-04 | 2000-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR035511A1 true AR035511A1 (es) | 2004-06-02 |
Family
ID=22950114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010105609A AR035511A1 (es) | 2000-12-04 | 2001-12-03 | Procedimiento para preparar una cefalosporina e intermediarios de sintesis |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20020198375A1 (enExample) |
| EP (1) | EP1339722A1 (enExample) |
| JP (1) | JP2004520293A (enExample) |
| KR (1) | KR100526379B1 (enExample) |
| CN (1) | CN1243755C (enExample) |
| AR (1) | AR035511A1 (enExample) |
| AU (2) | AU2394302A (enExample) |
| BR (1) | BR0115870A (enExample) |
| CA (1) | CA2436848C (enExample) |
| CZ (1) | CZ20031525A3 (enExample) |
| HU (1) | HUP0400642A3 (enExample) |
| IL (1) | IL155714A0 (enExample) |
| MX (1) | MXPA03004937A (enExample) |
| PL (1) | PL362144A1 (enExample) |
| RU (1) | RU2237670C1 (enExample) |
| WO (1) | WO2002046198A1 (enExample) |
| ZA (1) | ZA200303670B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030051895A (ko) * | 2000-12-04 | 2003-06-25 | 후지사와 야꾸힝 고교 가부시키가이샤 | 아미노티아졸 유도체의 무수물의 제조 방법 |
| US7378408B2 (en) * | 2001-11-30 | 2008-05-27 | Pfizer Inc. | Methods of treatment and formulations of cephalosporin |
| EP1725568A1 (en) * | 2004-03-09 | 2006-11-29 | Pfizer Products Inc. | Process for preparing cephalosporin intermediates using alpha-iod o-1-azetidineacetic acid esters and trialkylphosphites |
| CN103797053B (zh) | 2011-05-04 | 2017-06-20 | 康奈尔大学 | 多嵌段共聚物膜及其制备方法和用途 |
| CN103874697A (zh) | 2011-08-03 | 2014-06-18 | 协和发酵麒麟株式会社 | 二苯并氧杂*衍生物 |
| CN102718779B (zh) * | 2012-05-25 | 2015-07-29 | 深圳致君制药有限公司 | 注射用头孢唑肟钠及其制备方法、原料药头孢唑肟钠的合成方法 |
| CN105254648B (zh) * | 2015-11-13 | 2018-04-03 | 广东温氏大华农生物科技有限公司 | 一种头孢维星及其钠盐的合成方法 |
| WO2018229580A1 (en) * | 2017-06-14 | 2018-12-20 | Aurobindo Pharma Ltd | An improved process for the preparation of cefovecin sodium |
| CN111107924B (zh) | 2017-09-19 | 2022-12-27 | 特拉波雷技术有限公司 | 耐化学品的均孔交联嵌段共聚物结构 |
| JP7495353B2 (ja) * | 2018-04-04 | 2024-06-04 | テラポア テクノロジーズ，インコーポレイテッド | カプセル化粒子分画装置、それらのシステム及び使用方法 |
| US11051804B2 (en) * | 2018-07-02 | 2021-07-06 | DePuy Synthes Products, Inc. | Orthopedic fixation system and method of use thereof |
| GB2575261B (en) | 2018-07-02 | 2022-03-09 | Norbrook Lab Ltd | Intermediates in the synthesis of C3-substituted cephalosporins |
| CN110396034A (zh) * | 2019-07-31 | 2019-11-01 | 上海应用技术大学 | 一种烯丙基化合物的制备方法 |
| CN111187284A (zh) * | 2020-03-10 | 2020-05-22 | 赵俊瑶 | 一种头孢克洛的制备方法 |
| CN111892612A (zh) * | 2020-07-31 | 2020-11-06 | 重庆医药高等专科学校 | 一种以青霉素钾盐为原料制备头孢维星的中间体异构化物及其制备方法 |
| CN112321611B (zh) * | 2020-10-29 | 2022-05-06 | 湖北凌晟药业有限公司 | 一种头孢沙定母核的制备方法 |
| CN115873021A (zh) * | 2022-12-19 | 2023-03-31 | 华北制药集团动物保健品有限责任公司 | 一种头孢维星钠的制备方法 |
| CN116731039B (zh) * | 2023-06-12 | 2025-02-18 | 重庆汉佩生物科技有限公司 | 头孢维星衍生物的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY106399A (en) * | 1990-07-24 | 1995-05-30 | Pfizer | Cephalosporins and homologeus, preparation and pharmaceutical composition |
| US6001997A (en) * | 1990-07-24 | 1999-12-14 | Bateson; John Hargreaves | Cephalosporins and homologues, preparations and pharmaceutical compositions |
| GB9212609D0 (en) * | 1992-06-13 | 1992-07-29 | Smithkline Beecham Plc | Novel compounds |
| GB9424847D0 (en) * | 1994-12-09 | 1995-02-08 | Smithkline Beecham Plc | Novel process |
| GB2300856A (en) * | 1995-05-16 | 1996-11-20 | Pfizer Ltd | Beta-lactam preparation |
| GB0019124D0 (en) * | 2000-08-03 | 2000-09-27 | Pfizer | Novel process |
| RU2237671C1 (ru) * | 2000-12-04 | 2004-10-10 | Пфайзер Продактс Инк. | Способ и сложноэфирные производные, используемые для получения цефалоспоринов |
-
2001
- 2001-11-22 CN CNB018199623A patent/CN1243755C/zh not_active Expired - Fee Related
- 2001-11-22 IL IL15571401A patent/IL155714A0/xx unknown
- 2001-11-22 JP JP2002547935A patent/JP2004520293A/ja active Pending
- 2001-11-22 CZ CZ20031525A patent/CZ20031525A3/cs unknown
- 2001-11-22 MX MXPA03004937A patent/MXPA03004937A/es active IP Right Grant
- 2001-11-22 WO PCT/IB2001/002225 patent/WO2002046198A1/en not_active Ceased
- 2001-11-22 PL PL01362144A patent/PL362144A1/xx not_active Application Discontinuation
- 2001-11-22 CA CA002436848A patent/CA2436848C/en not_active Expired - Fee Related
- 2001-11-22 AU AU2394302A patent/AU2394302A/xx active Pending
- 2001-11-22 BR BR0115870-8A patent/BR0115870A/pt not_active IP Right Cessation
- 2001-11-22 HU HU0400642A patent/HUP0400642A3/hu unknown
- 2001-11-22 AU AU2002223943A patent/AU2002223943B2/en not_active Ceased
- 2001-11-22 KR KR10-2003-7007396A patent/KR100526379B1/ko not_active Expired - Fee Related
- 2001-11-22 RU RU2003116519/04A patent/RU2237670C1/ru active
- 2001-11-22 EP EP01999227A patent/EP1339722A1/en not_active Withdrawn
- 2001-12-03 AR ARP010105609A patent/AR035511A1/es not_active Application Discontinuation
- 2001-12-04 US US10/006,279 patent/US20020198375A1/en not_active Abandoned
-
2003
- 2003-05-13 ZA ZA200303670A patent/ZA200303670B/en unknown
-
2004
- 2004-02-11 US US10/776,795 patent/US7129350B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030070043A (ko) | 2003-08-27 |
| WO2002046198A1 (en) | 2002-06-13 |
| AU2394302A (en) | 2002-06-18 |
| AU2002223943B2 (en) | 2006-10-05 |
| US20040167327A1 (en) | 2004-08-26 |
| EP1339722A1 (en) | 2003-09-03 |
| CN1243755C (zh) | 2006-03-01 |
| ZA200303670B (en) | 2004-05-13 |
| PL362144A1 (en) | 2004-10-18 |
| CN1478093A (zh) | 2004-02-25 |
| RU2237670C1 (ru) | 2004-10-10 |
| CZ20031525A3 (cs) | 2004-04-14 |
| IL155714A0 (en) | 2003-11-23 |
| HK1059435A1 (en) | 2004-07-02 |
| US7129350B2 (en) | 2006-10-31 |
| JP2004520293A (ja) | 2004-07-08 |
| KR100526379B1 (ko) | 2005-11-08 |
| HUP0400642A2 (hu) | 2004-06-28 |
| CA2436848A1 (en) | 2002-06-13 |
| MXPA03004937A (es) | 2003-09-10 |
| US20020198375A1 (en) | 2002-12-26 |
| CA2436848C (en) | 2008-12-02 |
| BR0115870A (pt) | 2004-02-03 |
| HUP0400642A3 (en) | 2010-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2076325T3 (es) | Procedimiento e intermedios para preparar compuestos que tienen un resto acetileno disustituido y actividad biologica del tipo acido retinoico. | |
| ES8606262A1 (es) | Procedimiento para preparar derivados de pleuromutilina | |
| AR041275A1 (es) | Compuestos de isotiazol e isoxazol como inhibidores del factor de crecimiento transformador (tgf) y composicion farmaceutica | |
| ATE123754T1 (de) | Phenylethenylverbindungen mit retenoidähnlicher wirkung. | |
| BRPI0116967B8 (pt) | derivado de pirazina ou um sal deste, composição farmacêutica, e, derivado de fluoropirazina ou um sal deste | |
| MA20582A1 (fr) | Derives de benzoxazole et benzothiazolamine | |
| HU9300915D0 (en) | 1-/2-(aryl-sulphonyl-amino)-1-oxo-ethyl/-piperidine derivatives, method for producing them and pharmaceutical preparatives containing said compounds as active substance | |
| MA26457A1 (fr) | Vinylpyrrolidone-cephalosporines a substituants basiques, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation | |
| BR0115870A (pt) | Processos de acoplamento e intermediários úteis para preparação de cefalosporinas | |
| ES2201166T3 (es) | Procedimiento de racemizacion para su utilizacion en la fabricacion de levobupivacaina y agentes anestesicos correspondientes a base de piperidincarboxanilida. | |
| EP0497001A3 (en) | Oxidized-type glutathione alkyl ester | |
| AR060690A1 (es) | Polimeros que contienen magnesio para la hiperfosfatemia | |
| PE20030356A1 (es) | Isoxazolopiridinona | |
| AR035076A1 (es) | Procedimiento y derivados ester utiles para la preparacion de cefalosporinas | |
| AR039475A1 (es) | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa | |
| AR127139A1 (es) | Inhibidores de lpxc y usos de estos | |
| KR900009677A (ko) | 신규 화합물들 | |
| RU2011108420A (ru) | Стабилизированный фармацевтический состав | |
| MA20210A1 (fr) | Procede de preparation de nouveaux derives de l'acide 4 - phenyl 4-oxo buten-2-oique. | |
| PE20000645A1 (es) | Derivados de 3-(2-oxo-[1,3`]bipirrolidinil-3-ilidenmetil)-cefemos | |
| DE69008069D1 (de) | Antipsychotische Verbindungen. | |
| ES8200691A1 (es) | Procedimiento para la preparacion de nuevas cefalosporinas | |
| ES433982A1 (es) | Procedimiento para la preparacion de agentes antihelminti- cos. | |
| PT88463A (pt) | Process for the preparation of macrolide compounds and of compositions containing them | |
| PT88462A (pt) | Process for the preparation of macrolide compounds and of compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal | ||
| FB | Suspension of granting procedure |